Professional Documents
Culture Documents
0108 CAPA - VanTrieste Martin P9 FINAL
0108 CAPA - VanTrieste Martin P9 FINAL
0108 CAPA - VanTrieste Martin P9 FINAL
Agenda
What is CAPA?
Other Industries
Case Study:
How CAPA developed in Biotech
The Desired State
Enablers for an Effective CAPA System
Lessons Learned
Summary
2
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
4
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
Agenda
What is CAPA?
Other Industries
Case Study:
How CAPA developed in Biotech
The Desired State
Enablers for an Effective CAPA System
Lessons Learned
Summary
6
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
160
Transistors Per
Chip (Millions)
140 500
120 400
100
80 300
60 200
40
100
20
0 0
1991 1993 1995 1997 1999 2001 2003 2005
Year
Planned obsolesce
New competition
Loss of market share
Improved product quality
But
Quality is free at the end of the day, if you can get it right
Source: PriceWaterhouseCoopers Presentation, FDA Science Board Meeting November 16, 2001
11
12
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
Agenda
What is CAPA?
Other Industries
Case Study:
How CAPA developed in Biotech
The Desired State
Enablers for an Effective CAPA System
Lessons Learned
Summary
15
Stuff Happens
10 Non-conformances
Expand scope; emphasize
investigation quality; little risk
System with Numbers
Today
Prior to 1995
More trending & holistic Non-conformances
Deviation Reports
review of data Risk based, Strong
Report only major departures identifying preventive Governance with action
from procedure oriented management review
actions
17
18
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
Strong Governance
Vet appropriateness of corrective actions
and timelines
Management Review
Defined metrics plan
Escalation process
Management commitment
19
Agenda
What is CAPA?
Other Industries
Case Study:
How CAPA developed in Biotech
The Desired State
Enablers for an Effective CAPA System
Lessons Learned
Summary
20
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
TableII:ApplicationofCorrectiveActionandPreventiveActionSystemThroughouttheProduct
Lifecycle
21
The Future
22
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
Agenda
What is CAPA
Other Industries
Case Study
How CAPA developed in Biotech
The Desired State
Enablers for an Effective CAPA System
Lessons Learned
Summary
23
25
Agenda
What is CAPA
Other Industries
Case Study
How CAPA developed in Biotech
The Desired State
Enablers for an Effective CAPA System
Lessons Learned
Summary
26
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
Lessons Learned
Law of Unintended Consequences
Numbers can Risk Based
overwhelm
Artificial Realistic dates &
timelines interim reports
Metrics & bad Choose right
behaviors metrics
Lessons Learned
28
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
7
6
7
07
7
06
07
-0
-0
l -0
-0
l -0
-0
p-
p-
n-
v
v
ay
ar
Ju
Ju
No
No
Se
Se
Fewer significant & repetitive deviations
Ja
07
07
7
06
7
-0
l-0
l-0
-0
-0
n-
p-
p-
-
ar
ay
Ja 06
A -06
S -06
O 06
O 07
N -07
7
N -06
D 06
Fe 7
M 7
A 07
M -07
Ju 07
Ju 07
A 07
S -07
ov
ov
Ju
Ju
-0
-0
-0
Se
Se
Ja
-
-
-
-
-
l-
M
ec
ug
ug
n
ep
ov
ay
ov
b
ep
ct
ct
ar
pr
l
M
N
Ju
Agenda
What is CAPA
Other Industries
Case Study
How CAPA developed in Biotech
The Desired State
Enablers
Lessons Learned
Summary
30
P9: Pharmaceutical Quality System Elements:
Continual Improvement of the Process (CAPA) By Martin VanTrieste
Summary
31
Thank You
32